We are delighted to announce that a new biomarker panel will soon be available to complement and expand on Olink’s ever-growing library of high quality protein assays.
Olink®NEURO EXPLORATORY will enable simultaneous measurement of 92 proteins using just 1 µL of plasma, serum, CSF, or other types of human sample, and includes a combination of exploratory and established markers with a focus on neurology-related diseases, and biological processes such as axon development, neurogenesis and synapse assembly. The established proteins include Neurofilament light polypeptide (Uniprot no. P07196)*, which is an important marker for degenerative neurological diseases and traumatic brain injury.
This new panel will:
- Facilitate a larger-scale screening approach to protein biomarker discovery, taking Olink’s library to over 1070 different human protein assays
- Be a perfect complement to our neurological disease-focused panel, Olink® NEUROLOGY, enabling a wider, more exploratory approach to neurological studies
- Continue Olink’s commitment to provide the scientific community with the tools it needs for protein biomarker discovery, development and implementation in the journey towards precision medicine
*The assay for Neurofilament light polypeptide uses the NF-light® antibodies from UmanDiagnostics, Umeå Sweden.
Olink® NEURO EXPLORATORY is expected to be available either for shipment as a kit, or via one of our Analysis Service labs at the end of August, 2018.
If you would like to see a preliminary version of the complete biomarker list for thepanel (details subject to change until validation has been completed), or if you have any questions about this new panel, please us the buttons below: